New painkiller goes head-to-head with standard treatment for back pain sufferers
NCT ID NCT06595004
First seen Dec 24, 2025 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tested a new pain medication called HCP1004 against an existing one (RLD2401) in 310 adults with chronic low-back pain lasting at least 3 months. The goal was to see if the new drug works just as well and is safe. Participants rated their pain using a scale, and researchers also tracked disability, quality of life, and stomach side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanyang University Seoul Hospital
Seoul, Seoul, 04763, South Korea
Conditions
Explore the condition pages connected to this study.